Ameritas Investment Partners’s Aratana Therapeutics, Inc. PETX Stock Holding History

Ameritas Investment Partners’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3,555	Closed	-$18K	–	3100
2019 Q2	$18K	Hold	3,555	–	–	﹤0.01%	2519
2019 Q1	$13K	Hold	3,555	–	–	﹤0.01%	2620
2018 Q4	$22K	Hold	3,555	–	–	﹤0.01%	2299
2018 Q3	$21K	Hold	3,555	–	–	﹤0.01%	2494
2018 Q2	$15K	Hold	3,555	–	–	﹤0.01%	2679
2018 Q1	$16K	Hold	3,555	–	–	﹤0.01%	2547
2017 Q4	$19K	Hold	3,555	–	–	﹤0.01%	2466
2017 Q3	$20K	Hold	3,555	–	–	﹤0.01%	2428
2017 Q2	$26K	Buy	3,555 +1,366	+62%	+$8.4K	﹤0.01%	2322
2017 Q1	$12K	Buy	+2,189	New	+$14.8K	﹤0.01%	2645

Other funds holding PETX

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Ameritas Investment Partners's PETX Position: Q3 2019 in Review

Ameritas Investment Partners sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 3,555 shares — an estimated $18K sold.

Ameritas Investment Partners first reported a position in PETX in Q1 2017 and held it in 10 quarters. The position peaked at $26K in Q2 2017. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

Ameritas Investment Partners reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Ameritas Investment Partners sold 3,555 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $18K.
Ameritas Investment Partners first reported a position in Aratana Therapeutics, Inc. in Q1 2017 and held it in 10 quarters.
Ameritas Investment Partners's Aratana Therapeutics, Inc. position peaked at $26K in Q2 2017.
2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Ameritas Investment Partners's 13F filing for Q3 2019, filed 14 Nov 2019.